Skip to main content

Peer Review reports

From: Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?

Original Submission
7 Mar 2017 Submitted Original manuscript
5 May 2017 Author responded Author comments - Robert Kemp
23 Mar 2017 Reviewed Reviewer Report - Robert Hills
26 Mar 2017 Reviewed Reviewer Report - Rajeshwari Sridhara
22 Mar 2017 Reviewed Reviewer Report - Ariel Alonso
22 Mar 2017 Reviewed Reviewer Report - Daniel Normolle
Resubmission - Version 2
5 May 2017 Submitted Manuscript version 2
7 Jun 2017 Author responded Author comments - Robert Kemp
11 May 2017 Reviewed Reviewer Report - Robert Hills
30 May 2017 Reviewed Reviewer Report - Ariel Alonso
8 May 2017 Reviewed Reviewer Report - Daniel Normolle
Resubmission - Version 3
7 Jun 2017 Submitted Manuscript version 3
Publishing
26 Jun 2017 Editorially accepted
21 Jul 2017 Article published 10.1186/s12916-017-0902-9

You can find further information about peer review here.

Back to article page
\